$APVO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aptevo Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aptevo Therapeutics Inc.. Get notifications about new insider transactions in Aptevo Therapeutics Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2021 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 0.00 | 893 | 0 | 893 | |
| Jun 02 2021 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 26.15 | 2,678 | 70,030 | 2,678 | |
| Jun 02 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 0.00 | 893 | 0 | 893 | |
| Jun 02 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 26.15 | 2,678 | 70,030 | 2,678 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 0.00 | 14,375 | 0 | 14,375 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 33.50 | 43,125 | 1,444,688 | 43,125 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 0.00 | 5,500 | 0 | 5,500 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 33.50 | 16,500 | 552,750 | 16,500 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 0.00 | 5,500 | 0 | 5,500 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 33.50 | 16,500 | 552,750 | 16,500 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
| Feb 17 2021 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.87 | 2,650 | 63,256 | 1,760,000 | 1.8 M to 1.8 M (+0.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.48 | 107,901 | 2,533,515 | 1,757,350 | 1.6 M to 1.8 M (+6.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 22.33 | 29,682 | 662,799 | 1,649,449 | 1.6 M to 1.6 M (+1.83 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.63 | 34,044 | 702,328 | 1,619,767 | 1.6 M to 1.6 M (+2.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.94 | 8,482 | 177,613 | 1,585,723 | 1.6 M to 1.6 M (+0.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.78 | 137,241 | 2,851,868 | 1,577,241 | 1.4 M to 1.6 M (+9.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.79 | 171,626 | 4,082,983 | 1,440,000 | 1.3 M to 1.4 M (+13.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.32 | 71,241 | 1,091,412 | 1,268,374 | 1.2 M to 1.3 M (+5.95 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 14.22 | 77,133 | 1,096,831 | 1,197,133 | 1.1 M to 1.2 M (+6.89 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.31 | 160,000 | 2,449,600 | 1,120,000 | 960 K to 1.1 M (+16.67 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.84 | 160,000 | 2,694,400 | 960,000 | 800 K to 960 K (+20.00 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.33 | 60,146 | 982,184 | 800,000 | 739.9 K to 800 K (+8.13 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.65 | 99,854 | 1,363,007 | 739,854 | 640 K to 739.9 K (+15.60 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.83 | 160,000 | 2,212,800 | 640,000 | 480 K to 640 K (+33.33 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.11 | 88,379 | 1,158,649 | 480,000 | 391.6 K to 480 K (+22.57 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 10.63 | 68,296 | 725,986 | 391,621 | 323.3 K to 391.6 K (+21.12 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.87 | 2,650 | 63,256 | 1,760,000 | 1.8 M to 1.8 M (+0.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.48 | 107,901 | 2,533,515 | 1,757,350 | 1.6 M to 1.8 M (+6.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 22.33 | 29,682 | 662,799 | 1,649,449 | 1.6 M to 1.6 M (+1.83 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.63 | 34,044 | 702,328 | 1,619,767 | 1.6 M to 1.6 M (+2.15 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.94 | 8,482 | 177,613 | 1,585,723 | 1.6 M to 1.6 M (+0.54 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 20.78 | 137,241 | 2,851,868 | 1,577,241 | 1.4 M to 1.6 M (+9.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 23.79 | 171,626 | 4,082,983 | 1,440,000 | 1.3 M to 1.4 M (+13.53 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.32 | 71,241 | 1,091,412 | 1,268,374 | 1.2 M to 1.3 M (+5.95 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 14.22 | 77,133 | 1,096,831 | 1,197,133 | 1.1 M to 1.2 M (+6.89 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 15.31 | 160,000 | 2,449,600 | 1,120,000 | 960 K to 1.1 M (+16.67 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.84 | 160,000 | 2,694,400 | 960,000 | 800 K to 960 K (+20.00 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 16.33 | 60,146 | 982,184 | 800,000 | 739.9 K to 800 K (+8.13 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.65 | 99,854 | 1,363,007 | 739,854 | 640 K to 739.9 K (+15.60 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.83 | 160,000 | 2,212,800 | 640,000 | 480 K to 640 K (+33.33 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 13.11 | 88,379 | 1,158,649 | 480,000 | 391.6 K to 480 K (+22.57 %) |
| Nov 06 2020 | APVO | Aptevo Therapeutic ... | TANG KEVIN C | 10% Owner | Buy | P | 10.63 | 68,296 | 725,986 | 391,621 | 323.3 K to 391.6 K (+21.12 %) |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 7,380 | 63,173 | 7,380 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 8.56 | 7,380 | 63,173 | 7,380 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 41.58 | 3,128 | 130,062 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 35.70 | 1,928 | 68,830 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 41.58 | 3,128 | 130,062 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 34.58 | 2,695 | 93,193 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 35.70 | 1,928 | 68,830 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | D | 34.58 | 2,695 | 93,193 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 7,784 | 66,631 | 7,784 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 8.56 | 7,784 | 66,631 | 7,784 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 41.58 | 3,908 | 162,495 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 35.70 | 2,779 | 99,210 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 41.58 | 3,908 | 162,495 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 34.58 | 2,072 | 71,650 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 35.70 | 2,779 | 99,210 | 0 | |
| Jul 31 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | D | 34.58 | 2,072 | 71,650 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | A | 8.56 | 2,140 | 18,318 | 2,140 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | A | 8.56 | 6,423 | 54,981 | 6,423 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 21.28 | 4,814 | 102,442 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 43.82 | 4,814 | 210,949 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 30.10 | 2,407 | 72,451 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 27.44 | 2,407 | 66,048 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP of Operations, ... | Option Exercise | D | 41.16 | 5,357 | 220,494 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | A | 8.56 | 4,813 | 41,199 | 4,813 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | A | 8.56 | 16,625 | 142,310 | 16,625 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 21.28 | 10,828 | 230,420 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 43.82 | 10,828 | 474,483 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 30.10 | 5,414 | 162,961 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 27.44 | 5,414 | 148,560 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 41.16 | 14,319 | 589,370 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | CEO and President | Option Exercise | D | 25.20 | 2,545 | 64,134 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 8.56 | 170 | 1,455 | 170 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 8.56 | 1,322 | 11,316 | 1,322 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | D | 76.86 | 1,785 | 137,195 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | D | 30.10 | 892 | 26,849 | 0 | |
| Jul 29 2020 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | D | 41.16 | 1,339 | 55,113 | 0 | |
| Mar 19 2020 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 0.50 | 303,200 | 150,994 | 303,200 | |
| Mar 19 2020 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Option Exercise | A | 0.50 | 134,800 | 67,130 | 134,800 | |
| Mar 19 2020 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP Operations, CMO | Option Exercise | A | 0.50 | 134,800 | 67,130 | 134,800 | |
| Mar 19 2020 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 0.50 | 134,800 | 67,130 | 134,800 | |
| Mar 19 2020 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 0.50 | 134,800 | 67,130 | 134,800 | |
| Mar 19 2020 | APVO | Aptevo Therapeutic ... | Adelman Michael | SVP, Commercial Ope ... | Option Exercise | A | 0.50 | 134,800 | 67,130 | 134,800 | |
| Nov 05 2019 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 0.58 | 189,894 | 109,379 | 189,894 | |
| Nov 05 2019 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Option Exercise | A | 0.58 | 120,968 | 69,678 | 120,968 | |
| Nov 05 2019 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP Operations, CMO | Option Exercise | A | 0.58 | 122,359 | 70,479 | 122,359 | |
| Nov 05 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 0.58 | 135,384 | 77,981 | 135,384 | |
| Nov 05 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 0.58 | 122,982 | 70,838 | 122,982 | |
| Nov 05 2019 | APVO | Aptevo Therapeutic ... | Adelman Michael | SVP, Commercial Ope ... | Option Exercise | A | 0.58 | 114,247 | 65,806 | 114,247 | |
| Aug 19 2019 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP Operations, CMO | Buy | P | 0.76 | 25,000 | 19,000 | 75,000 | 50 K to 75 K (+50.00 %) |
| Aug 13 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Buy | P | 0.76 | 100,000 | 75,520 | 1,124,536 | 1 M to 1.1 M (+9.76 %) |
| Jul 30 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.83 | 55,015 | 45,861 | 1,024,536 | 969.5 K to 1 M (+5.67 %) |
| Jul 24 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.90 | 10,000 | 8,996 | 969,521 | 959.5 K to 969.5 K (+1.04 %) |